Facial Emotion Recognition in Insomnia and Emotional Regulation
A legfontosabb adatok
- Ki végzi
- University Hospital, Angers
- Hol
- Angers (Franciaország)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 128 fő, tervezett
- Kezdés
- 2025. dec. 12.
- Várható befejezés
- 2027. szept. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Facial emotion recognition test with and without eye-tracking and Cognitive Emotion Regulation. Questionnaire (CERQ)
- A regiszteradat frissítve
- 2026. április 6.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with chronic insomnia and adults without insomnia as a control group. It compares how well each group recognises emotions on faces.
- Életkor
- 18 to 65 years
- Nem
- All sexes
- A betegség stádiuma
- Insomnia group: known insomnia treated as such, with an ISI (Insomnia Severity Index) score above 14 (15 to 28). Control group: ISI score below 8 (0 to 7), no known insomnia.
- Korábbi kezelés
- Insomnia group: must be treated for insomnia. People taking antidepressant, neuroleptic or thymoregulator (mood stabiliser) medicine cannot join. People taking a benzodiazepine with a long half-life (>12 hours) cannot join.
A részvétel fő kizáró okai
- Known psychiatric disorders, or ones found at the psychiatric interview, including active addiction (tobacco excepted)
- Known after-effects of a nerve disease, or a worsening neurological disease
- Known significant eye condition
- Pregnancy or breast-feeding
- A hospital stay needed in the month before the study
A regiszter feltételei, szó szerint
Mind a 19 feltétel megnézéseKevesebb
Ki vehet részt
- Insomnia group: ISI >14 (between 15 and 28 = clinical insomnia)
- Control group: ISI < 8 (between 0 and 7 = no insomnia); Non-pre-inclusion criteria
- Known psychiatric disorders (Characterized depressive episode, Bipolar disorder, Schizophrenia and other delusional disorders, Specified anxiety disorder (social anxiety, generalized anxiety disorder), Obsessive-compulsive disorder (OCD), Eating disorders, Neurodevelopmental disorders (ASD, ADHD), Active addictive disorders (excluding tobacco), ...)
- Taking antidepressant, neuroleptic or thymoregulator medication
- Taking a benzodiazepine with a long half-life (>12 hours)
- Condition requiring hospitalization in the month preceding the study
- Known sequelae or progressive neurological disease
- Known significant ophthalmological condition
- Pregnancy or breast-feeding
- Person deprived of liberty by judicial or administrative decision
- Person subject to a legal protection measure
- Person under psychiatric care without consent
- For control group: no known insomnia; Non-inclusion criteria :
- Psychiatric disorders identified during psychiatric interview
Egyéb feltételek
- Pre-inclusion criteria
- Age between 18 and 65
- Signed consent to participate in the study
- Person affiliated to or benefiting from a social security scheme
- For insomnia group: known insomnia (patient treated for insomnia)
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 65 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Franciaország.
- CHU AngersAngers, FranciaországContact: Bénédicte GohierRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Introduction Chronic insomnia is a prevalent disorder in the general population, affecting up to 20% according to French National Institute of Health and Medical Research, leading to a decline in quality of life and an increased risk of developing certain psychiatric disorders, notably major depressive episodes. Chronic insomnia, particularly when accompanied by reduced sleep duration, has been associated with cognitive impairments documented in the literature, such as reduced concentration, working memory, vigilance, and certain executive functions.
A teljes eredeti leírásKevesebb
While some studies suggest subjective cognitive impairment in insomnia, it remains inconclusive when objectively measured. Individuals with chronic insomnia often report a global deterioration in social life, characterized by irritability, attentional difficulties, asthenia, and social isolation. This raises questions about potential impairments in social abilities, particularly in recognizing facial emotions, which may be linked to the subjective complaints of reduced quality of life in individuals with insomnia.
Several studies have explored facial emotion recognition in insomnia, with some indicating impairments in emotion recognition or evaluation of emotion intensity. Others demonstrated deficits in recognizing specific emotions (such as anger) or representations (such as fatigue), which were associated with attentional deficits and changes in visual fixation points in eye-tracking studies.
However, some authors found no significant association between insomnia complaints and impaired facial emotion recognition. Facial emotion recognition has been studied using eye-tracking in major depressive episodes, attention-deficit/hyperactivity disorder (ADHD), and autism spectrum disorders. Eye-tracking studies have revealed attentional biases toward negative emotions in depression and deficits in visual attention to the eye region in autism, contributing to impaired facial emotion recognition. To date, no study has compared facial emotion recognition abilities between individuals with insomnia and a control group, considering attentional deficits and emotional dysregulation described in insomnia.
Methods The study aims to compare two groups: one with isolated insomnia (without associated psychiatric disorders) and a control group (without insomnia or psychiatric disorders). Patients with psychiatric or addictive disorders will be excluded based on Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-V) psychiatric interviews. Participants aged over 65 or under 18 will also be excluded to mitigate potential biases related to dementia and cognitive alterations not related to insomnia.
The insomnia group will consist of individuals seeking care at the Sleep Center of Angers University Hospital for chronic insomnia (lasting more than 3 months). Insomnia will be confirmed using the Insomnia Severity Index (ISI), with a score exceeding 15, while individuals with subclinical insomnia (ISI score between 7 and 15) will be excluded. The control group will have an ISI score below 7 (indicating the absence of insomnia).
The main objective is to determine whether facial emotion recognition differs between the insomnia and control groups. Secondary objectives include assessing differences between explicit facial emotion recognition tests (controlled conditions) and eye-tracking tests (implicit memory) in both groups to evaluate attentional biases. Additionally, the study aims to explore differences in facial emotion recognition tests based on emotional regulation profiles (adaptive or non-adaptive regulation).
Expected Results The hypothesis is that facial emotion recognition under controlled conditions (explicit memory) will not differ between the insomnia and control groups. However, differences are expected in implicit memory tests (eye-tracking) due to the attentional deficits previously described in insomnia. Additionally, variations in facial emotion recognition are anticipated based on emotional regulation profiles, which may influence facial emotion recognition in insomnia.
The study's findings could contribute to a better understanding of cognitive complaints related to insomnia, especially in the realm of social interactions, by objectively assessing and specifying potential biases. This research may also inform targeted therapeutic approaches, particularly in cognitive-behavioral therapy, focusing on cognitive remediation and restructuring. Ultimately, the study's outcomes could guide the development of specific rehabilitation programs centered on facial emotion recognition, emotional deficits, and emotional dysregulation in insomnia.
A vizsgálat 2 csoportja
- InsomniaA vizsgált kezelés
Kezelés: Facial emotion recognition test with and without eye-tracking and Cognitive Emotion Regulation. Questionnaire (CERQ)
- ControlMár használt kezelés, összehasonlításként
Kezelés: Facial emotion recognition test with and without eye-tracking and Cognitive Emotion Regulation. Questionnaire (CERQ)
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT06251258: ki vehet részt
- A regiszteradat frissítve
- 2026. április 6.